Summary Topical Absorbable Hemostats (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Wound Care ...

Johnson & Johnson Wound Management has introduced the SURGIFOAM Absorbable Gelatin Sponge for use in oral surgery. This new sponge is the latest addition to J&J’s line of absorbable hemostats.

Topical Absorbable Hemostatic agents, also known as passive hemostats (collagen, gelatin, polysaccharide, oxidized regenerated cellulose and combination hemostats), consist of the integration of an ...

According to Report Ocean, global topical absorbable hemostats market is projected to grow at a CAGR of 6.2% during the forecast period 2020-2026. Topical absorbable hemostats consist of the ...

These products integrate absorbable sponges, foams, or pads with hemostatic agents, effectively addressing diffuse nonanatomic bleeding, sensitive structure-related bleeding, and hemostatic ...

The global absorbable hemostats market reached a value of nearly $3.14 billion in 2024, having grown at a compound annual growth rate (CAGR) of 5.90% since 2019. The market is expected to grow ...

Ax-Surgi Surgical Hemostat, a chitosan-based hemostat for controlling severe surgical bleeding, developed by Axio Biosolutions, has received the US Food and Drug Administration (FDA) 510(k) clearance.

The hemostat is fully absorbable within 1 to 2 weeks. Surgicel Powder should not be used to control hemorrhage from large arteries. For more information call (877) 384-4266 or visit Ethicon.com.

The FDA recommends that users of absorbable hemostatic agents review the device labeling, especially contraindications, warnings, and precautions. If these agents are to be used near bony or ...